WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 28, 2005, 25(39):8889-8897; doi:10.1523/JNEUROSCI.2577-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCloskey, D. P.
Right arrow Articles by Scharfman, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCloskey, D. P.
Right arrow Articles by Scharfman, H. E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Depression of Synaptic Transmission by Vascular Endothelial Growth Factor in Adult Rat Hippocampus and Evidence for Increased Efficacy after Chronic Seizures

Daniel P. McCloskey,1 Susan D. Croll,2,3,4 and Helen E. Scharfman1,5

1Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, New York 10993, 2Department of Psychology, and Neuropsychology and Neuroscience Doctoral Subprograms, Queens College, Flushing, New York 11367, 3Graduate Center of City University of New York, New York, New York 10016, 4Regeneron Pharmaceuticals, Tarrytown, New York 10591, and 5Departments of Pharmacology and Neurology, Columbia University, College of Physicians and Surgeons, New York, New York 10032

In addition to its potent effects on vasculature, it has become clear that vascular endothelial growth factor (VEGF) has effects on both neurons and glia, and recent studies suggest that it can be neuroprotective. To determine potential mechanisms underlying this neuroprotection, recombinant human VEGF was bath applied to adult rat hippocampal slices, and both extracellular and intracellular recordings were used to examine intrinsic properties and synaptic responses of hippocampal principal neurons. Initial studies in area CA1 showed that VEGF significantly reduced the amplitude of responses elicited by Schaffer collateral stimulation, without influencing membrane properties. Similar effects occurred in CA3 pyramidal cells and dentate gyrus granule cells when their major glutamatergic afferents were stimulated. Because VEGF expression is increased after seizures, effects of VEGF were also examined in rats with recurrent spontaneous seizures. VEGF reduced spontaneous discharges in slices from these rats but had surprisingly little effect on epileptiform discharges produced by disinhibition of slices from control rats. These results demonstrate a previously unknown effect of VEGF on neuronal activity and also demonstrate a remarkable potency in the epileptic brain. Based on this, we suggest that VEGF or VEGF-related targets could provide useful endpoints to direct novel therapeutic strategies for epilepsy.

Key words: anticonvulsant; hippocampus; intracellular; neuromodulation; synaptic transmission; VEGF


Received June 22, 2005; revised August 15, 2005; accepted August 17, 2005.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet
Role and Therapeutic Potential of VEGF in the Nervous System
Physiol Rev, April 1, 2009; 89(2): 607 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Marko and D. H. Damon
VEGF promotes vascular sympathetic innervation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2646 - H2652.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. Rigau, M. Morin, M.-C. Rousset, F. de Bock, A. Lebrun, P. Coubes, M.-C. Picot, M. Baldy-Moulinier, J. Bockaert, A. Crespel, et al.
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Brain, July 1, 2007; 130(7): 1942 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Nishijima, Y.-S. Ng, L. Zhong, J. Bradley, W. Schubert, N. Jo, J. Akita, S. J. Samuelsson, G. S. Robinson, A. P. Adamis, et al.
Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury
Am. J. Pathol., July 1, 2007; 171(1): 53 - 67.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Warner-Schmidt and R. S. Duman
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
PNAS, March 13, 2007; 104(11): 4647 - 4652.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-